Is Ultragenyx Pharmaceutical Inc. (RARE) a Buy, Sell, or Hold?
NASDAQ : RARE
Ultragenyx Pharmaceutical Inc. — Earnings Estimates
$24.91 USD
-$1.13 (-4.34%)
- Volume
- 1.54M
- Average Volume
- 2.19M
- Market Capitalization
- $2.45B
- P/E Ratio
- -4.08
- Dividend Yield
- 0.00%
- Price Target
- $43.00
- Year High
- $39.89
- Year Low
- $18.29
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.02
Annual earnings financials
RARE financial data with annual/quarterly toggle
Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.
RARE Estimated and Actual Revenue by Quarter
RARE Estimated and Actual EPS by Quarter
RARE Analyst Forecasts — EBITDA & EBIT
| Quarter Date | No of Estimates | Ebitda | Ebit | ||||
|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | ||
| 2027-12-31 | 5 | -328.32M | -282.82M | -303.78M | -336.67M | -290.01M | -311.5M |
| 2027-09-30 | 5 | -253.17M | -218.09M | -234.24M | -259.6M | -223.63M | -240.2M |
| 2027-06-30 | 5 | -234.44M | -201.95M | -216.92M | -240.4M | -207.09M | -222.43M |
| 2027-03-31 | 5 | -194.96M | -167.94M | -180.39M | -199.92M | -172.21M | -184.97M |
| 2026-12-31 | 5 | -238.96M | -205.84M | -221.1M | -245.03M | -211.08M | -226.72M |
| 2026-09-30 | 10 | -172.18M | -161.89M | -168.46M | -176.56M | -166M | -172.74M |
RARE Analyst Forecasts — Net Income & SGA Expense
| Quarter Date | No of Estimates | NetIncome | SgaExpense | ||||
|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | ||
| 2027-12-31 | 5 | 58.61M | 71.15M | 64.38M | 199.13M | 231.17M | 213.89M |
| 2027-09-30 | 5 | -1.11M | -915.78K | -1.01M | 153.55M | 178.25M | 164.93M |
| 2027-06-30 | 5 | -25.75M | -21.22M | -23.31M | 142.19M | 165.07M | 152.73M |
| 2027-03-31 | 5 | -78.45M | -64.63M | -70.99M | 118.25M | 137.27M | 127.01M |
| 2026-12-31 | 5 | -49.71M | -40.95M | -44.99M | 144.93M | 168.25M | 155.67M |
| 2026-09-30 | 10 | -147.79M | 27.63M | -102.13M | 113.98M | 121.23M | 118.61M |
RARE Analyst Forecasts — Revenue & EPS
| Quarter Date | No of Revenue Estimates | Revenue | No of EPS Estimates | EPS | ||||
|---|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | |||
| 2027-12-31 | 5 | 311.38M | 361.47M | 334.45M | 2 | 0.58261 | 0.70721 | 0.64 |
| 2027-09-30 | 5 | 240.1M | 278.73M | 257.89M | 1 | -0.01105018 | -0.00910323 | -0.01 |
| 2027-06-30 | 5 | 222.34M | 258.11M | 238.82M | 1 | -0.256 | -0.21089 | -0.23167 |
| 2027-03-31 | 5 | 184.9M | 214.64M | 198.6M | 2 | -0.77982 | -0.64242 | -0.70571 |
| 2026-12-31 | 5 | 226.63M | 263.08M | 243.42M | 2 | -0.49415 | -0.40709 | -0.44719 |
| 2026-09-30 | 10 | 178.23M | 189.57M | 185.47M | 4 | -1.46905 | 0.2747 | -1.0152 |